CAS 25899-70-1|Xanthosine 5'-monophosphate sodium salt
| Common Name | Xanthosine 5'-monophosphate sodium salt | ||
|---|---|---|---|
| CAS Number | 25899-70-1 | Molecular Weight | 408.16900 |
| Density | / | Boiling Point | / |
| Molecular Formula | C10H11N4Na2O9P | Melting Point | / |
| MSDS | USA | Flash Point | / |
Names
| Name | 5'-Xanthylic Acid Disodium Salt |
|---|---|
| Synonym | More Synonyms |
Xanthosine 5'-monophosphate sodium salt BiologicalActivity
| Description | Xanthosine 5'-monophosphate sodium salt (5'-Xanthylic acid sodium salt) is an intermediate in purine metabolism. Xanthosine 5'-monophosphate sodium salt can be used for genetic code, nucleic acid structure, and DNA, RNA and protein synthesis research[1]. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
| In Vitro | Microbiological production of Xanthosine 5'-monophosphate sodium salt (XMP) in high yields opens the way for its use in foods as a flavoring agent and as a chemical intermediate for production of purine antimetabolites. Xanthosine 5'-monophosphate sodium salt also should prove valuable in the production of synthetic polynucleotides for studies on the genetic code, protein synthesis, and nucleic acid structure[1]. |
| References | [1]. A L Demain, et al. Production of xanthosine-5'-monophosphate and inosine-5'-monophosphate by auxotrophic mutants of a coryneform bacterium. Appl Microbiol. 1965 Sep;13(5):757-61. |
Chemical & Physical Properties
| Molecular Formula | C10H11N4Na2O9P |
|---|---|
| Molecular Weight | 408.16900 |
| Exact Mass | 408.00600 |
| PSA | 215.46000 |
| InChIKey | QQPVYRBCIRHGSZ-LGVAUZIVSA-L |
| SMILES | O=P(O)(O)OCC1OC(n2cnc3c([O-])nc([O-])nc32)C(O)C1O.[Na+].[Na+] |
| Storage condition | -20°C |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3.0 |
Articles3
More Articles| Injectable cryogel-based whole-cell cancer vaccines. Nat. Commun. 6 , 7556, (2015) A biomaterial-based vaccination system that uses minimal extracorporeal manipulation could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where DCs interface with transpl... | |
| GMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway. Mol. Microbiol. 97 , 1006-20, (2015) The causative agent of human African trypanosomiasis, Trypanosoma brucei, lacks de novo purine biosynthesis and depends on purine salvage from the host. The purine salvage pathway is redundant and con... | |
| Sensitive and validated LC-MS/MS methods to evaluate mycophenolic acid pharmacokinetics and pharmacodynamics in hematopoietic stem cell transplant patients. Biomed. Chromatogr. 29 , 1309-16, (2015) Monitoring of pharmacodynamics in addition to pharmacokinetics is one of strategies to individualize mycophenolate mofetil therapy. The purpose of this study was to develop sensitive liquid chromatogr... |
Synonyms
| EINECS 247-324-0 |
| XANTHOSINE 5'-MONOPHOSPHATE DISODIUM SALT |
| MFCD00037982 |
